A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Clinical trial NCT04779320 · RECRUITING

Trial details

NCT number: NCT04779320
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease (CD)

Start date: 2022-02-10
Primary completion: 2027-09-13
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.